Table 1.
Survivals: RFA versus hepatic resection for HCC.
| Author/Year | Study type |
n
(RFA/resection) |
Mean tumor size (cm) (RFA/resection) |
Overall survival (%) (RFA versus resection) |
P |
|---|---|---|---|---|---|
| Chen et al. [15], 2006 | RCT | 90/90 | ND/ND | 65.9 versus 64.0 (4-year) | NS |
| Huang et al. [16], 2010 | RCT | 115/115 | ND/ND | 54.78 versus 75.65 (5-year) | .001 |
| Vivarelli et al. [17], 2004 | Retrospective | 79/79 | ND/ND | 33 versus 65 (3-year) | .002 |
| Montorsi et al. [18], 2005 | Prospective | 58/40 | ND/ND | 30 versus 53 (4-year) | .018 |
| Ogihara et al. [19], 2005 | Retrospective | 40/47 | 4.6/7.4 | 39 versus 31 (5-year) | .79 |
| Wakai et al. [20], 2006 | Retrospective | 64/85 | ND/ND | 30 versus 53 (10-year) | .012 |
| Guglielmi et al. [21], 2008 | Retrospective | 23/33 | ND/ND | 45 versus 55 (5-year) | .7 |
| Abu-Hilal et al. [22], 2008 | Retrospective | 34/34 | 3.0/3.8 | 57 versus 56 (5-year) | .3 |
| Hiraoka et al. [23], 2008 | Retrospective | 105/59 | ND/ND | 59.3 versus 59.4 (5-year) | NS |
| Ueno et al. [24], 2009 | Retrospective | 123/110 | 2.0/2.7 | 63 versus 80 (5-year) | .06 |
| Takayama et al. [25], 2009 | Retrospective | 1315/1235 | 1.6/1.8 | 95 versus 94 (2-year) | .28 |
HCC: hepatocellular carcinoma; ND: not described; NS: not significant; RFA: radiofrequency ablation.